Zimmer Biomet stock gains on leadership reshuffle and strong valuation signals
Published on 09/15/2026 at 13:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Zimmer Biomet Holdings, Inc. stock (ISIN US98956P1021) closed at USD 96.54 on the New York Stock Exchange on September 14, 2026, up 3.3 percent from the previous close of USD 93.49 and highlighting renewed investor interest in the medical technology group.
Leadership reshuffle puts focus on Americas and robotics
According to Simply Wall St on September 14, 2026, Zimmer Biomet recently reshaped its senior ranks, promoting executives Gary Campbell, Brian Hatcher and Bradley Kessler while Group President Kevin Thornal departed as part of a wider restructuring focused on its Americas region and robotics portfolio.
The same analysis notes that the company’s fair value estimates suggest around 15 percent upside versus the current share price, with various valuation views for Zimmer Biomet ranging from roughly USD 107.57 to USD 227.81 per share in different models, underlining how the leadership changes could influence long term strategy and growth expectations.Simply Wall St
Valuation metrics and recent performance
On the valuation side, Zimmer Biomet shares are trading notably below some intrinsic value estimates. As GuruFocus reported on September 14, 2026, the current price of USD 96.54 stands around 22.8 percent below a GF Value estimate of USD 125.01 per share, implying that the stock is considered undervalued on that proprietary metric.
GuruFocus assigns Zimmer Biomet a GF Score of 72 out of 100, which the portal describes as indicating above average overall performance potential based on profitability, growth, financial strength and other factors aggregated in its scoring system.GuruFocus
Despite the latest uptick, the same GuruFocus overview highlights that Zimmer Biomet stock is still down 5.4 percent over the past year and 6.5 percent over the last three years, showing that the recent move occurs against a backdrop of subdued longer term share performance.GuruFocus
Market capitalization figures underline Zimmer Biomet’s size in the global healthcare landscape. As of mid September 2026, Zimmer Biomet’s market cap stands at approximately USD 18.41 billion, placing the company around 1,268th among the world’s most valuable listed firms by market value according to data compiled by CompaniesMarketCap.
The same source notes that Zimmer Biomet’s reported market capitalization on September 13, 2026 was USD 17.83 billion, meaning the latest reading of USD 18.41 billion represents an increase of roughly 3.3 percent in market value in line with the most recent share price gain.CompaniesMarketCap
Dividend, equity duration and risk context
In addition to capital gains potential, Zimmer Biomet offers a modest dividend stream. Per data on the Zimmer Biomet quote page from Yahoo Finance, the company has announced a cash dividend of USD 0.24 per share with an ex dividend date of September 30, 2026, providing income oriented investors with a scheduled payout as part of the total return profile.
Risk characteristics also enter the picture via equity duration measures. A recent overview from TradingView featuring Seeking Alpha content on September 14, 2026 cites Zimmer Biomet with an equity duration of around 19.7 years in a Goldman Sachs basket of short duration health care stocks, situating the company among peers such as Cigna and Biogen in terms of sensitivity of future cash flows to interest rate changes.
For investors, the combination of an above average GF Score, apparent valuation discount to certain intrinsic value models, a moderate dividend and long dated equity duration underscores a nuanced risk reward balance, especially in light of the mixed share performance over multi year horizons and ongoing management changes.
Zimmer Biomet stock price level and trading data
Zimmer Biomet shares trade on the New York Stock Exchange under the ticker ZBH. According to price data on September 14, 2026, the stock closed at USD 96.54, with an intraday move of USD 3.05 corresponding to a 3.26 percent gain versus the prior close of USD 93.49, and an after hours indication of USD 97.31 adding a further 0.80 percent.Yahoo Finance
The same quote snapshot shows a 52 week trading range for Zimmer Biomet stock between USD 79.12 on the low end and USD 106.88 on the high end as of mid September 2026, meaning the latest closing price of USD 96.54 sits roughly USD 17.42 above the 52 week low and USD 10.34 below the 52 week high, indicating that the shares are mid range in their one year band with room to either retest prior highs or drift back toward the lower bound depending on forthcoming news and market sentiment.GuruFocus
Zimmer Biomet stock key data
- Company: Zimmer Biomet Holdings, Inc.
- ISIN: US98956P1021
- Ticker: ZBH
- Trading venue: NYSE
- Price (as of September 14, 2026, 04:00): 96.54 USD
- Market capitalization: 18.41 billion USD (as of September 2026)
- Sector / Industry: Health Care / Medical Technology
- Index membership: S&P 500
- Next earnings date: September 30, 2026
More news and analyses on Zimmer Biomet Holdings, Inc. stock
